✦ LIBER ✦

Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer

✍ Scribed by Guomin Wang; Meifang Song; Huaiyu Xu; Yi Fang

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 600 KB
Volume: 34
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(95)02111-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which

Randomized trials of radiotherapy alone

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysis

✍ Jean-Pierre Pignon; Lesley A. Stewart 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

arino et al.' have performed a meta-analysis using data extracted M from published randomized trials comparing radiotherapy (RT) to RT plus chemotherapy (CT) in Stage IIIA and IIIB unresectable nonsmall cell lung cancer (NSCLC). They identified 14 trials published between 1980 and 1994. The odds rat

Randomized trials of radiotherapy alone

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

✍ Pietro Marino; Armando Preatoni; Alessandra Cantoni 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

Background. For patients with Stage I11 nonsmall cell lung cancer (NSCLC), radiation is the standard treatment, but survival remains poor. The authors performed a meta-analysis study using clinical trials that evaluated combined radiotherapy plus chemotherapy versus radiotherapy alone in patients wi

Toxicity and outcome of a phase II trial

Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer

✍ Ana M. Rojas; Basil E. Lyn; Elena M. Wilson; Frances J. Williams; Nihal Shah; Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Phase II trial of combined radiotherapy

Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC)

✍ Gerrit Van Harskamp; Epie Boven; Jan B. Vermorken; Henk Van Deutekom; Jaap Stam; 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Prospective randomized study of four nov

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network trial

✍ F. Anthony Greco; James R. Gray Jr.; Dana S. Thompson; Howard A. Burris III; Joa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND The authors compared the toxicity, response rate, and progression free survival of four chemotherapy regimens for patients with advanced (Stage IIIB and IV) nonsmall cell lung carcinoma. ## METHODS A total of 267 patients entered this randomized Phase II trial on one of